The study found that carfilzomib and irinotecan have
a potential synergistic effect in SCLC and other Irinotecan - sensitive cancers by allowing normal DNA damage repair and enabling normal cell - cycle death.
Not exact matches
However, there is a general thesis that because of the
potential for
synergistic effects, human exposure to all endocrine disrupters, such as the soy isoflavones, requires urgent reduction (8).
Studies assessing the
synergistic effects of diet and cancer treatment will hopefully provide more clues as to the
potential benefits of the diet, as well as identify those cancer patients who may benefit the most.